Merck opens vaccine manufacturing facility in North Carolina

(Reuters) -Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats.

Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.

Eli Lilly said last month it plans to invest at least $27 billion to build four new manufacturing plants in the U.S.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)

You May Also Be Interested In

• Daiwa Securities Upgrades Merck (MRK) to Outperform (2)
• CoreWeave soars after fifth straight quarter of record revenue, raised guide
• Dell, HPE gain pre-market as SMCI posts blowout revenue guidance